Brief: Isofol Strengthens Outlook For Further Extending Patent Protection Of Its Drug Candidate Arfolitixorin

Isofol Medical AB (publ)

17/09/2024 09:06

Sept 17 (Reuters) - Isofol Medical AB (publ)
 ISOFOL.ST :
    * ISOFOL STRENGTHENS THE OUTLOOK FOR FURTHER EXTENDING THE
PATENT
PROTECTION OF ITS DRUG CANDIDATE ARFOLITIXORIN
    * ENSUING PATENTS WILL HAVE AN EXPECTED EXPIRY IN MID- 2040S
    * IF GRANTED, PATENT COULD SIGNIFICANTLY STRENGTHEN AND
PROLONG
ARFOLITIXORIN'S INTELLECTUAL PROPERTY PROTECTION INTERNATIONALLY
    * A NEW PRODUCT PATENT COVERING ARFOLITIXORIN IS LIKELY (BUT
NOT
GUARANTEED) TO BE GRANTED OVER NEXT 2-3 YEARS

Source text for Eikon:  ID:nMFN3FZGK4 
Further company coverage:  ISOFOL.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))